at least Lazard sees value around these prices, increased their stake between $4.20-$4.30 over the last week.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025